Winton Group LTD Kal Vista Pharmaceuticals, Inc. Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$12.88 - $19.47 $198,699 - $300,363	-15,427 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$9.83 - $13.99 $5,121 - $7,288	521 Added 3.5%	15,427 $194,000
Q2 2020 Aug 05, 2020	BUY	$6.75 - $12.89 $2,038 - $3,892	302 Added 2.07%	14,906 $180,000
Q1 2020 May 11, 2020	SELL	$5.8 - $18.56 $113,888 - $364,444	-19,636 Reduced 57.35%	14,604 $112,000
Q4 2019 Feb 13, 2020	BUY	$10.31 - $17.81 $353,014 - $609,814	34,240 New	34,240 $610,000

135

52M

551K

98K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $240M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.